SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Phase III Data for Teva Pharmaceutical Industries Limited’s QNASL® (beclomethasone dipropionate) Demonstrate Efficacy Profile in Pediatric Patients With Seasonal Allergic Rhinitis